One and Only
Personalized medicine is not perfect, but it is personal. CLP looks at some new tests on the market to see how personal they are.
Read More
Search Results for: lung cancer
Clovis Oncology, Ventana to Develop Companion Diagnostic Test for CO-101
Clovis Oncology Inc and Ventana Medical Systems Inc announced that they have entered into a collaboration agreement for the development of a human equilibrative nucleoside transporter 1 (hENT1) immunohistochemistry (IHC) assay.
Read MoreRadient Pharmaceuticals Expands Onko-Sure Commercialization
Through its US-based subsidiary AMDL Diagnostics Inc, Radient Pharmaceuticals Corp announced that it plans to expand its worldwide commercialization strategy for its Onko-Sure in vitro diagnostic cancer test to include CLIA laboratory testing services.
Read MoreQIAGEN Drives The Development Of Companion Diagnostics With Two Key Appointments
QIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read MoreNew Data Indicate Effectiveness of Clarient’s Pulmotax for Lung Cancer
Clarient Inc has announced that data from a new study suggest that the Clarient Insight Dx Pulmotax assay may effectively predict which lung cancer patients will respond favorably to chemotherapy.
Read More